Sorrento Therapeutics Inc.

04/09/2021 | Press release | Distributed by Public on 04/09/2021 13:07

Scilex Holding, a Subsidiary of Sorrento, Has Received From FDA a sNDA Approval for ZTlido® Label Expansion